RM

Rodney S. Markin

Director at Cardiff Oncology

Dr. Markin has been a Director since February 2014. He is currently Vice President for Network Development, Nebraska Medicine and Associate Vice Chancellor for Business and Executive Director of the UNeTech Institute at the University of Nebraska Medical Center, a public center of health sciences research, patient care, and education, where he has served since July 1985. Dr. Markin also serves concurrently as Courtesy Professor of Psychiatry and Courtesy Professor of Surgery at the University of Nebraska and David T. Purtilo Distinguished Professor of Pathology and Microbiology since 2005 and Professor of Pathology and Microbiology. He serves on the boards of Perceptimed Inc. since 2014, MikroScan Technologies Inc. since 2015, Afaxys Inc. since 2017, and Paradigm Diagnostics Inc. since 2018. In the non-profit sector, Dr. Markin serves as a Director of Children’s Hospital and Medical Center Foundation and as Trustee for Keck Graduate Institute, and the Make-A-Wish Foundation, since 2015. Previously, Dr. Markin served as Chief Technology Officer and Associate Vice Chancellor for Business Development at the University of Nebraska from 2011 to 2017, and as Director of Transgenomic, Inc. from 2007 to 2014. The Board believes Dr. Markin’s medical insight, board experience and executive experience in institutional healthcare qualifies him to serve as a director of our company.

Timeline

  • Director

    Current role